BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roberson ML, Strassle PD, Fasehun LO, Erim DO, Deune EG, Ogunleye AA. Financial Burden of Lymphedema Hospitalizations in the United States. JAMA Oncol 2021;7:630-2. [PMID: 33599683 DOI: 10.1001/jamaoncol.2020.7891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Rockson SG, Karaca-Mandic P, Nguyen M, Shadduck K, Gingerich P, Campione E, Hetrrick H. A non-randomized, open-label study of the safety and effectiveness of a novel non-pneumatic compression device (NPCD) for lower limb lymphedema. Sci Rep 2022;12:14005. [PMID: 35977981 DOI: 10.1038/s41598-022-17225-9] [Reference Citation Analysis]
2 Aldrich MB, Rasmussen JC, DeSnyder SM, Woodward WA, Chan W, Sevick-Muraca EM, Mittendorf EA, Smith BD, Stauder MC, Strom EA, Perkins GH, Hoffman KE, Mitchell MP, Barcenas CH, Isales LE, Shaitelman SF. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging. Breast Cancer Res Treat 2022;195:33-41. [PMID: 35816269 DOI: 10.1007/s10549-022-06667-4] [Reference Citation Analysis]
3 Cortina CS, Yen TWF, Bergom C, Fields B, Craft MA, Currey A, Kong AL. Breast cancer-related lymphedema rates after modern axillary treatments: How accurate are our estimates? Surgery 2021:S0039-6060(21)00789-3. [PMID: 34736790 DOI: 10.1016/j.surg.2021.08.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Blei F. Update April 2021. Lymphat Res Biol 2021;19:189-202. [PMID: 33900826 DOI: 10.1089/lrb.2021.29102.fb] [Reference Citation Analysis]